Back to Journals » OncoTargets and Therapy » Volume 12

Overexpression of APC11 predicts worse survival in lung adenocarcinoma [Corrigendum]

Authors Zhou J, Zhang S, Fu G, He Z, Xu Y, Ye W, Chen Z

Received 17 April 2019

Accepted for publication 17 April 2019

Published 2 May 2019 Volume 2019:12 Pages 3361—3362

DOI https://doi.org/10.2147/OTT.S212589


Zhou J, Zhang S, Fu G, et al. Onco Targets Ther. 2018;11:7125–7132.

Author intended to show unrepresentative images of cell migration and invasion, that the number of migration cells was similar with invasion cells in Figure 4, page 7129. The published image for Figure 4B was not consistent with the author’s expectation. Author repeated the assay test and received better and reasonable images for replacement. These replacement of images to Figure 4B and C have not changed the overall results to the study. The author apologizes for this error.

Read the original article.


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]